SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
FDA Approves Boehringer Ingelheim Corporation's Combivent(R) Respimat(R) (ipratropium bromide and albuterol) Inhalation Spray for the Treatment of Patients with Chronic Obstructive Pulmonary Disease